# Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients

> **NCT04698785** · PHASE2 · RECRUITING · sponsor: **Centre Leon Berard** · enrollment: 36 (estimated)

## Conditions studied

- Bone Sarcoma
- Osteosarcoma

## Interventions

- **DRUG:** Treatment by regorafenib and best supportive care

## Key facts

- **NCT ID:** NCT04698785
- **Lead sponsor:** Centre Leon Berard
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-21
- **Primary completion:** 2026-07-21
- **Final completion:** 2026-07-21
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04698785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04698785, "Efficacy of Regorafenib Combined With Best Supportive Care as Maintenance Treatment in High Grade Bone Sarcomas Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04698785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*